OmegAMP preprint: generative AI designs programmable antimicrobial peptides, 204 experimentally validated with in vivo efficacy
AllThingsApx · x · 2026-09-16
A new bioRxiv preprint from the de la Fuente lab at UPenn, with Helmholtz Munich and TUM, introduces OmegAMP — a generative AI approach that moves from producing candidate molecules to designing peptides with controllable properties. The model controls fundamental physicochemical properties (length, charge, hydrophobicity) and supports analog and motif-guided design. The team experimentally characterized 204 peptides, identifying potent antimicrobials, multifunctional molecules, and lead designs with in vivo efficacy against A. baumannii. The broader goal: using machines not just to discover biological function but to engineer it for human health.
More from Research
- Open-source climbing CV tool uses SAM3.1 and pose models to quantify your hand and foot placements — spillai · 2026-09-16
- Sloman's 1981 paper: emotions are inevitable in machines managing multiple motives — yeastsplainer · 2026-09-16
- fal's H3 Max: RL post-training cuts 5s video generation from 120s to under 3s — isidentical · 2026-09-16
- Agent theory researcher quits, calling the work "emotionally taxing" — IgorCarron · 2026-09-16
- Science LLM benchmarks have flawed answers; fixing them significantly raises model scores — Profanion · 2026-09-16
- Aaronson hears AI companies have cracked longstanding TCS open problems, sitting on major announcements — scaling01 · 2026-09-16